Atherosclerosis [26], nonalcoholic fatty liver disease [27], cancer [28], and dementia [29] are only a few of the contexts in which a downregulation or absence of NNMT can visibly impact the cellular phenotype in a physiologically significant manner. The gene discussed is NNMT; the disease is metabolic dysfunction-associated steatotic liver disease.